Erratum: First-in-Class Anti-immunoglobulin-like Transcript 4 Myeloid-Specific Antibody MK-4830 Abrogates a PD-1 Resistance Mechanism in Patients with Advanced Solid Tumors (Clin Cancer Res (2022) 28 (57–70) DOI: 10.1158/1078-0432.CCR-22-0564)

Lillian L. Siu; Ding Wang; John Hilton; Ravit Geva; Drew Rasco; Ruth Perets; Anson K. Abraham; Douglas C. Wilson; Julia F. Markensohn; Jared Lunceford; Leah Suttner; Shabana Siddiqi; Rachel A. Altura; Corinne Maurice-Dror

doi:10.1158/1078-0432.CCR-22-2320

Erratum: First-in-Class Anti-immunoglobulin-like Transcript 4 Myeloid-Specific Antibody MK-4830 Abrogates a PD-1 Resistance Mechanism in Patients with Advanced Solid Tumors (Clin Cancer Res (2022) 28 (57–70) DOI: 10.1158/1078-0432.CCR-22-0564)

Lillian L. Siu, Ding Wang, John Hilton, Ravit Geva, Drew Rasco, Ruth Perets, Anson K. Abraham, Douglas C. Wilson, Julia F. Markensohn, Jared Lunceford, Leah Suttner, Shabana Siddiqi, Rachel A. Altura, Corinne Maurice-Dror

Clinical Departments

Research output: Contribution to journal › Comment/debate

Abstract

In the original version of this article (1), the Spearman correlations were correct in the text and incorrect in Fig. 4. The figure has been corrected in the latest online HTML and PDF versions of the article. The authors regret the error.

Original language	English
Pages (from-to)	4158
Number of pages	1
Journal	Clinical Cancer Research
Volume	28
Issue number	18
DOIs	https://doi.org/10.1158/1078-0432.CCR-22-2320
State	Published - 15 Sep 2022

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1158/1078-0432.CCR-22-2320

Fingerprint

Dive into the research topics of 'Erratum: First-in-Class Anti-immunoglobulin-like Transcript 4 Myeloid-Specific Antibody MK-4830 Abrogates a PD-1 Resistance Mechanism in Patients with Advanced Solid Tumors (Clin Cancer Res (2022) 28 (57–70) DOI: 10.1158/1078-0432.CCR-22-0564)'. Together they form a unique fingerprint.

Cite this

Siu, L. L., Wang, D., Hilton, J., Geva, R., Rasco, D., Perets, R., Abraham, A. K., Wilson, D. C., Markensohn, J. F., Lunceford, J., Suttner, L., Siddiqi, S., Altura, R. A., & Maurice-Dror, C. (2022). Erratum: First-in-Class Anti-immunoglobulin-like Transcript 4 Myeloid-Specific Antibody MK-4830 Abrogates a PD-1 Resistance Mechanism in Patients with Advanced Solid Tumors (Clin Cancer Res (2022) 28 (57–70) DOI: 10.1158/1078-0432.CCR-22-0564). Clinical Cancer Research, 28(18), 4158. https://doi.org/10.1158/1078-0432.CCR-22-2320

@article{62fd3902bd9e4529b7017db232506fdd,

title = "Erratum: First-in-Class Anti-immunoglobulin-like Transcript 4 Myeloid-Specific Antibody MK-4830 Abrogates a PD-1 Resistance Mechanism in Patients with Advanced Solid Tumors (Clin Cancer Res (2022) 28 (57–70) DOI: 10.1158/1078-0432.CCR-22-0564)",

abstract = "In the original version of this article (1), the Spearman correlations were correct in the text and incorrect in Fig. 4. The figure has been corrected in the latest online HTML and PDF versions of the article. The authors regret the error.",

author = "Siu, {Lillian L.} and Ding Wang and John Hilton and Ravit Geva and Drew Rasco and Ruth Perets and Abraham, {Anson K.} and Wilson, {Douglas C.} and Markensohn, {Julia F.} and Jared Lunceford and Leah Suttner and Shabana Siddiqi and Altura, {Rachel A.} and Corinne Maurice-Dror",

note = "Publisher Copyright: {\textcopyright} 2022 American Association for Cancer Research.",

year = "2022",

month = sep,

day = "15",

doi = "10.1158/1078-0432.CCR-22-2320",

language = "אנגלית",

volume = "28",

pages = "4158",

journal = "Clinical Cancer Research",

issn = "1078-0432",

publisher = "American Association for Cancer Research Inc.",

number = "18",

}

Siu, LL, Wang, D, Hilton, J, Geva, R, Rasco, D, Perets, R, Abraham, AK, Wilson, DC, Markensohn, JF, Lunceford, J, Suttner, L, Siddiqi, S, Altura, RA & Maurice-Dror, C 2022, 'Erratum: First-in-Class Anti-immunoglobulin-like Transcript 4 Myeloid-Specific Antibody MK-4830 Abrogates a PD-1 Resistance Mechanism in Patients with Advanced Solid Tumors (Clin Cancer Res (2022) 28 (57–70) DOI: 10.1158/1078-0432.CCR-22-0564)', Clinical Cancer Research, vol. 28, no. 18, pp. 4158. https://doi.org/10.1158/1078-0432.CCR-22-2320

Erratum : First-in-Class Anti-immunoglobulin-like Transcript 4 Myeloid-Specific Antibody MK-4830 Abrogates a PD-1 Resistance Mechanism in Patients with Advanced Solid Tumors (Clin Cancer Res (2022) 28 (57–70) DOI: 10.1158/1078-0432.CCR-22-0564). / Siu, Lillian L.; Wang, Ding; Hilton, John et al.

In: Clinical Cancer Research, Vol. 28, No. 18, 15.09.2022, p. 4158.

Research output: Contribution to journal › Comment/debate

TY - JOUR

T1 - Erratum

T2 - First-in-Class Anti-immunoglobulin-like Transcript 4 Myeloid-Specific Antibody MK-4830 Abrogates a PD-1 Resistance Mechanism in Patients with Advanced Solid Tumors (Clin Cancer Res (2022) 28 (57–70) DOI: 10.1158/1078-0432.CCR-22-0564)

AU - Siu, Lillian L.

AU - Wang, Ding

AU - Hilton, John

AU - Geva, Ravit

AU - Rasco, Drew

AU - Perets, Ruth

AU - Abraham, Anson K.

AU - Wilson, Douglas C.

AU - Markensohn, Julia F.

AU - Lunceford, Jared

AU - Suttner, Leah

AU - Siddiqi, Shabana

AU - Altura, Rachel A.

AU - Maurice-Dror, Corinne

PY - 2022/9/15

Y1 - 2022/9/15

N2 - In the original version of this article (1), the Spearman correlations were correct in the text and incorrect in Fig. 4. The figure has been corrected in the latest online HTML and PDF versions of the article. The authors regret the error.

AB - In the original version of this article (1), the Spearman correlations were correct in the text and incorrect in Fig. 4. The figure has been corrected in the latest online HTML and PDF versions of the article. The authors regret the error.

UR - http://www.scopus.com/inward/record.url?scp=85138346741&partnerID=8YFLogxK

U2 - 10.1158/1078-0432.CCR-22-2320

DO - 10.1158/1078-0432.CCR-22-2320

M3 - ???researchoutput.researchoutputtypes.contributiontojournal.comment???

C2 - 36106403

AN - SCOPUS:85138346741

SN - 1078-0432

VL - 28

SP - 4158

JO - Clinical Cancer Research

JF - Clinical Cancer Research

IS - 18

ER -

Siu LL, Wang D, Hilton J, Geva R, Rasco D, Perets R et al. Erratum: First-in-Class Anti-immunoglobulin-like Transcript 4 Myeloid-Specific Antibody MK-4830 Abrogates a PD-1 Resistance Mechanism in Patients with Advanced Solid Tumors (Clin Cancer Res (2022) 28 (57–70) DOI: 10.1158/1078-0432.CCR-22-0564). Clinical Cancer Research. 2022 Sep 15;28(18):4158. doi: 10.1158/1078-0432.CCR-22-2320

Erratum: First-in-Class Anti-immunoglobulin-like Transcript 4 Myeloid-Specific Antibody MK-4830 Abrogates a PD-1 Resistance Mechanism in Patients with Advanced Solid Tumors (Clin Cancer Res (2022) 28 (57–70) DOI: 10.1158/1078-0432.CCR-22-0564)

Abstract

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this